Skip to main content
Visit genentech.com
REVOLUTIONIZING CARDIOVASCULAR, RENAL & METABOLIC CARE

Join the frontline of medical innovation in CVRM management
VIEW JOBS

Cardiovascular, renal, and metabolic (CVRM) diseases are rapidly emerging as a global public health crisis, affecting at least half of the world's population


These conditions lead to severe health complications and early mortality. Despite advancements in medical treatments, CVRM diseases frequently go undiagnosed and undertreated, resulting in escalating healthcare costs and an increasing societal burden. It is more urgent than ever to prioritize CVRM diseases on national health agendas, as their impact continues to expand, marking them as one of the most pressing issues in global health today.

The next health breakthrough starts here — together, let's shape the future of CVRM care.
Explore open positions and join our Talent Community to receive custom job notifications tailored to your interests.

MEET OUR PEOPLE


"At Roche and Genentech, thanks to our pharmaceutical and diagnostics divisions being under the same roof, exciting collaborations are taking place to reimagine how we approach cardiometabolic care as a whole to address the unmet needs of people living with obesity, diabetes, cardiovascular and kidney disorders. The goal is to move beyond treating these diseases as separate and instead provide holistic and personalised support from early diagnosis and treatment through to monitoring. By that we're not just developing new treatment options, we're building an innovative, holistic framework for long-term care that adapts to the patient, not the other way around."
Dr. Manu Chakravarthy
Senior Vice President and Global Head of Cardiovascular, Renal and Metabolism Product Development

OUR APPROACH

From diagnosis, to treatment to monitoring: we support people living with cardiometabolic diseases at every step of their way.
Diagnose

Diagnose
Advanced diagnostics provide precision detection
Diagnose

Treatment
Targeted treatment offers effective management
Diagnose

Monitoring
Continuous monitoring to ensue an optimal outcome

YOUR PATH TO INNOVATION WITH US


Our combined strength in pharmaceuticals and diagnostics offers you a unique opportunity to create innovative solutions that transform patient care.

Here’s what we offer:
Cutting-edge innovation: Join a team at the forefront of developing advanced treatments for CVRM diseases, driving significant advancements that can transform patient care.
A global platform: Make a global impact, collaborating across markets to bring breakthrough treatments to patients.
A culture of changemakers: Be part of a community known for its pioneering spirit, committed to bold goals, and having fun along the way.

CVRM NEWS & STORIES

Obesity_Howcanwechangethetrajectorytoimprovepeople’slivesacrosstheworld
Obesity: How can we change the trajectory to improve people’s lives across the world?
With over 4 billion people projected to be affected by 2035, obesity is linked to 200+ comorbidities, including type 2 diabetes, cardiovascular disease, and cancer. As the numbers rise, the strain on healthcare systems grows-so how can we address this urgent challenge?
READ More
Podcast
Digger Deeper into Obesity
Tune in to our podcast with Manu Chakravarthy, Global Cardiovascular and Metabolism lead, as he shares the societal impact of obesity and how cutting-edge therapies like GLP-1s could improve health beyond weight loss.
HEAR More
Podcast
The Streets and Deets of Obesity
Join podcast co-host Maria Wilson as she dives into cardiovascular disease and obesity. Tune in to hear Maria discuss the brain’s role in cardiometabolic health and the future of research in this field.
LISTEN NOW
RocheInnovationCenter
Roche Genentech Innovation Center
The new center will be a hub for both Roche and Genentech, bringing together expertise in Cardiovascular, Renal, and Metabolism, as well as for data science and Al specialists to drive innovation in drug discovery and development.
Learn More
NorthCarolinaManufacturing_Card
North Carolina Manufacturing Facility
The new 700,000 sq.ft facility in Holly Springs, NC will support Roche and Genentech’s future portfolio of next-generation obesity medicines. 
Learn More

BECOME PART OF A TRANSFORMATIVE JOURNEY
If you'd like to learn more about our innovative approach and our key partnerships, dive deeper on this page.
To learn more about Genentech as an employer, visit our “Benefits” page.